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Purpose: To evaluate results of carotid endarterectomy (CEA) in diabetic patients in a large single-center experience.
Methods: Over a 13-year period ending in December 2008, 4305 consecutive CEAs in 3573 patients were performed. All
patients were prospectively enrolled in a dedicated database. Interventions were performed in diabetic patients in 883
cases (20.5%; group 1) and in nondiabetics in the remaining 3422 (79.5%; group 2). Early results in terms of 30-day
stroke and death rates were analyzed and compared. Follow-up results were analyzed with Kaplan-Meier curves and
compared with log-rank test.
Results: Diabetic patients were more likely to be females and to have coronary artery disease, peripheral arterial disease,
hyperlipemia, and arterial hypertension than nondiabetics. There were no differences between the two groups in terms of
preoperative clinical status or degree of carotid stenosis. Interventions were performed under general anesthesia with
somatosensory-evoked potentials (SEPs) monitoring in 67% of the patients in both groups, while the remaining
interventions were performed under clinical monitoring. Shunt insertion (14% and 11%, respectively) and patch closure
rates (79% and 76%, respectively) were similar between the two groups. There were no differences between the two groups
in terms of neurological outcomes, while the mortality rate was higher in group 1 than in group 2 (P  .002; odds ratio
[OR], 3.5; 95% confidence interval [CI], 1.5-8.3); combined 30-day stroke and death rate was significantly higher in
group 1 (2%) than in group 2 (0.9%; P  .006; 95% CI, 1.2-3.9; OR, 2.2). At univariate analysis, perioperative risk of
stroke and death in diabetic patients was significantly higher in patients undergoing intervention with SEP cerebral
monitoring (95%CI, 0.9-39.9; OR, 5.9; P .01), and this was also confirmed bymultivariate analysis (95%CI, 1.1-23.1;
OR, 8.3; P .04). The same analysis in nondiabetics demonstrated that again the need for general anesthesia significantly
increased perioperative risk, but this was not significant at multivariate analysis. Follow-up was available in 96% of
patients, with a mean duration of 40 months (range, 1-166 months). There were no differences between the two groups
in terms of estimated 7-year survival (87.3% and 88.8%, respectively; 95%CI, 0.57-1.08; OR, 0.8) and stroke-free survival
(86.8% and 88.1%, respectively; 95% CI, 0.59-1.07; OR, 0.8). Diabetic patients had decreased severe (>70%) restenosis-
free survival rates at 7 years than nondiabetics (77.4% and 82.2%, respectively; 95% CI, 0.6-1; OR, 0.8; P  .05).
Univariate analysis demonstrated again that the use of instrumental cerebral monitoring significantly decreased
stroke-free survival in diabetics (P  .01; log rank, 10.1), and this was also confirmed by multivariate analysis (95% CI,
1.7-17.7; OR, 5.4; P  .005).
Conclusions: In our experience, the presence of diabetes mellitus increases three-fold the risk of perioperative death after
CEA, while there are no differences with nondiabetics in terms of perioperative stroke. However, the rate of stroke and
death at 30 days still remains below the recommended standards. During follow-up, this difference becomes negligible,
and results are fairly similar to those obtained in nondiabetics. Particular attention should be paid to patients undergoing
intervention under general anesthesia, who seem to represent a subgroup of diabetics at higher perioperative risk,
suggesting neurologic monitoring should be used when possible. ( J Vasc Surg 2010;:.)Carotid endarterectomy (CEA), when performed with
acceptably low perioperative morbidity and mortality rates,
still represents the gold standard for the treatment of ex-
tracranial carotid disease.1 In high-volume centers, the
30-day overall rate of stroke and death is typically under the
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doi:10.1016/j.jvs.2010.08.030levels recommended by published guidelines.2 When peri-
operative complication rates exceed these recommended
limits, the benefits of CEA dramatically decrease, particu-
larly in asymptomatic patients.3
For this reason, the identification of subgroups of pa-
tients at higher surgical risk seems to be necessary to allow
a proper selection of patients for surgical interventions.
Diabetes mellitus (DM) has been described by several
authors4-6 as a factor significantly affecting the results of
CEA, even if other articles reported conflicting results.7
Moreover, there are few data in the literature concerning
the analysis of risk factors influencing early and late results
in diabetics.8
The aim of this study was to evaluate early and late
results of CEA in diabetic patients in our experience, with
particular attention to clinical, anatomical, and technical
factors affecting early and long-term outcomes.
1
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From January 1996 to December 2008, 4305 consec-
utive CEAs in 3573 patients were performed at the Univer-
sity of Florence. Five hundred eighty cases had bilateral
intervention and 152 cases had reintervention performed.
Data concerning these interventions were prospectively
collected in a dedicated database containing 150 fields,
including anatomical, clinical, diagnostic, and technical
variables. This database also contains perioperative (30
days) results in terms of mortality and neurological mor-
bidity and all relevant clinical and diagnostic data collected
during follow-up.
A post-hoc analysis of this prospective database was
performed and two subgroups of patients were identified:
diabetic patients (730 patients, 883 interventions; group 1)
and nondiabetic patients (2843 patients, 3422 interven-
tions; group 2).
DM was defined as the need for specific drugs to
maintain metabolic control; patients with diet-controlled
diabetes or impaired glucose tolerance alone were not
included in the diabetic group.
The two groups of patients were compared in terms of
demographic data, common risk factors for atherosclerosis,
and comorbidities. Risk factors and comorbidities included
arterial hypertension (defined as blood pressure greater
than 130/85 mm Hg or the need for antihypertensive
drugs), hyperlipemia (defined as triglycerides and choles-
terol values200mg/dL), coronary artery disease (history
of myocardial infarction [MI], angina, previous coronary
revascularization), and peripheral arterial disease (ankle/
brachial index 0.9). Patients were considered to be
asymptomatic in the absence of neurological symptoms
(transient ischemic attack or stroke) within 6 months from
the intervention, and the degree of carotid stenosis was
measured with North American Symptomatic Carotid
Endarterectomy Trial criteria. Intraoperative data included
type of anesthesia, cerebral monitoring and protection, and
technique of carotid reconstruction.
The choice of anesthetic method was at the discretion
of the operating surgeon and of the anesthesiologist, but
patient’s preference was also taken into account. Patients
undergoing CEA under general anesthesia had cerebral
monitoring with somatosensory-evoked potentials (SEPs)
and selective shunt insertion on the basis of SEP abnormal-
ities.9 With local anesthesia or our previously described
Cooperative Patient General Anesthesia (CoPaGeA)10
technique, a carotid shunt was inserted on the basis of
clinical neurologic monitoring during carotid clamping. To
make our analysis simpler, in our results, we considered
both pure local anesthesia and CoPaGeA as a unique entity.
Neurological evaluation at 30 days was independently
performed in all the patients by an experienced neurologist
who assessed the presence of minor and major stroke.
Minor stroke was defined as any postoperative neurological
event lasting more than 24 hours with recovery in the
following weeks or months without or with minimal resid-
ual functional impairment. Major stroke was defined as anypostoperative neurological event lasting more than 24
hours with residual invalidity and/or inability. Clinical and
anatomical indications for surgery, intraoperative technical
features, and perioperative (30 days) results of interven-
tions were analyzed in terms of stroke and death with 2
test and Fisher’s exact test, when necessary. Univariate
analysis for 30-day stroke and death rate in the whole study
group and in the two subgroups separately was performed.
The analysis included the following risk factors: gender, age
higher than 79 years, coronary artery disease, peripheral
arterial disease, arterial hypertension, presence of contralat-
eral carotid occlusion, preoperative symptoms, kind of an-
esthesia and cerebral monitoring, shunt insertion, and the
type of reconstruction (patch closure or not). In diabetic
patients, the role of different medical treatment of diabetes
(orally treated DM or insulin-requiring DM) was also ana-
lyzed. Multivariate analysis (stepwise logistic regression
analysis) for the same outcome with the inclusion of the
factors resulted significant at univariate analysis was per-
formed. Statistical significance was defined as a P value less
than .05.
Follow-up was performed at 1, 3, 6, and 12 months,
and yearly thereafter by clinical exam and duplex scan. All
studies were performed using an Acuson Sequoia 512
Ultrasound System (Acuson Corporation, Mountain View,
Calif). Patients who did not complete follow-up examina-
tions had phone interviews. During the phone interview,
some points were assessed: patient’s survival and cause of
death, if known, neurological events, and their time of
appearance. Moreover, the patient was asked to report the
results of his last duplex ultrasound control, where it was
performed, to assess the status of operated internal carotid
artery. Additional data regarding long-term survival and
major cardiovascular events were obtained from the Re-
gional Health Care database.
Follow-up data were analyzed by life-table analysis
(Kaplan-Meier test) in terms of stroke, death, and signifi-
cant (70% North American Symptomatic Carotid Endar-
terectomy Trial criteria) restenosis, and results in the two
groups were compared by means of log-rank test. In pa-
tients of group 1, both univariate analysis of the above-
mentioned risk factors and multivariate analysis (Cox’s
regression), which included the significant factors from the
univariate analysis, were performed for late ipsilateral neu-
rological events.
Statistical analysis was performed by means of SPSS
15.0 for Windows (SPSS Inc, Chicago, Ill).
RESULTS
Demographic data, risk factors, comorbidities, and
clinical and anatomical status. There were significant
differences between the two groups of patients in terms of
demographic data, risk factors, and comorbidities (Table I).
Diabetic patients were more likely to be females and to have
coronary artery disease, peripheral arterial disease, hyperli-
pemia, and arterial hypertension than nondiabetics. The
majority of patients (652/730) had oral medication-
treated DM, and 78 patients had insulin-requiring DM.
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smokers and of patients older than 79 years. There were no
differences between the two groups in terms of clinical
presentation at the time of the operation, of degree of
carotid stenosis, and type of intervention (primary or sec-
ondary intervention; Table II).
Intraoperative details. Local anesthesia or CoPaGeA
with clinical monitoring was used in 286 interventions in
group 1 (32%) and in 1132 cases in group 2 (33%; P ns).
In the entire study group, general anesthesia was used in
73% of symptomatic patients and in 64% of asymptomatic
ones (P  .001), and the same difference was found among
both diabetics (73% and 64.5%; P  .007) and nondiabetics
(72.5% and 64%, respectively). Shunt insertion rate was
similar between the two groups (14% in group 1 and 11% in
group 2, P  ns). In group 1, the shunt insertion rate was
15% in patients undergoing local anesthesia or CoPaGeA
and 13% in patients done with general anesthesia; the
corresponding values in group 2 were 13.5% and 10%,
respectively. Concerning arterial reconstruction, a wide use
of patch closure was noted in both groups (79% in group 1
and 76% in group 2; P ns); similar percentages of primary
closure (17% and 19%, respectively), eversion technique
(3% in both groups), and of carotid bypass (1% and 2%,
Table I. Patients’ demographic data, risk factors, and
comorbidities
Group 1
(n  730)
Group 2
(n  2843) P
Female gender 252 (34.5%) 862 (30%) .03
Median age (years) 71.3 71.7 .6
Age 79 years 91 (12.5%) 455 (16%) .02
Hypercholesterolemia 313 (43%) 1245 (44%) .8
Hypertrigliceridemia 260 (35%) 827 (29%) .001
Arterial hypertension 535 (73%) 1897 (66%) .001
Coronary artery disease 186 (25%) 552 (10%) .001
Peripheral artery
disease 289 (39%) 764 (27%) .001
Smoker or past smoker 455 (62%) 1966 (69%) .01
Table II. Clinical and anatomical features
Group 1
(CEAs  883)
Group 2
(CEAs  3422) P
Presence of preoperative
symptoms 286 (33%) 1183 (35%) .6
Transient ischemic
attack 163 707
Minor stroke 39 142
Major stroke 14 33
Vertebrobasilar 70 301
Asymptomatic patients 597 (67%) 2239 (65%) .6
Degree of stenosis
60%-80% 370 (42%) 1501 (44%) .8
80% 488 (55%) 1809 (53%) .8
Near-occlusion 25 (3%) 112 (3%) .9
Contralateral occlusion 47 (5%) 203 (6%) .6
Redo surgery 26 (3%) 125 (3.5%) .6respectively) between the two groups were recorded.Early results. Perioperative results are reported in Ta-
ble III. There were no differences between the two groups
in terms of neurological outcomes; both postoperative
transient ischemic attack rates (0.8% and 0.5%, respectively)
and stroke rates (1.1% and 0.7%, respectively) were similar
between the two groups.Mortality rate was higher in group
1 than in group 2 (P  .002; odds ratio [OR], 3.5; 95%
confidence interval [CI], 1.5-8.3). Consequently, the 30-
day stroke and death rate was significantly higher in group
1 (2%) than in group 2 (0.9%; P  .006, 95% CI, 1.2-3.9;
OR, 2.2).
The rates of postoperative fatal (three cases in both
groups; 0.3% and 0.1%, respectively; P  ns) and nonfatal
(three cases in group 1 [0.4%], and 10 cases in group 2
[0.3%]; P  ns) acute MIs were similar in the two groups.
The cause of deaths in group 1 were stroke in two cases,
acute MI in three cases, intracranial haemorrhage in two
cases, acute respiratory failure in two cases, and ventricular
arrhythmia in the remaining one case. The cause of deaths
in group 2 were stroke in four cases, acute MI in three,
intracranial hemorrhage in two, massive pneumonia in one,
and rupture of an iliac aneurysm in the remaining one.
Univariate analysis for the risk of stroke and death at 30
days in the entire cohort of patients demonstrated that,
beyond diabetes, also the need for general anesthesia, the
need for shunting, and the performance of alternative arte-
rial reconstructions to patching significantly affected this
outcome (Table IV). At multivariate analysis, significance
was confirmed for all these risk factors.
Univariate analysis for the risk of stroke and death at 30
days in group 1 demonstrated that only instrumental mon-
itoring under general anesthesia increased perioperative
risk (Table V). Multivariate analysis confirmed that general
anesthesia (OR, 9.1; 95% CI, 1.1-63.5; P  .03) was
independently associated with an increased perioperative
risk of stroke and death. The separate analysis for stroke and
death demonstrated that the use of general anesthesia was
associated with an increased perioperative death rate (P 
.001) but not of stroke rate (P  .2).
The same analysis in group 2 demonstrated that again
the need for general anesthesia, the need for shunting, the
performance of alternative arterial reconstructions to
Table III. Perioperative (30 days) results
Group 1
(CEAs  883)
Group 2
(CEAs  3422) P
Postoperative stroke
Minor stroke 4 (0.4%) 16 (0.5%)
Major stroke 6 (0.7%)a 9 (0.2%)b
Cumulative stroke
rate 10 (1.1%) 25 (0.7%) .3
Death 10 (1.1%) 11 (0.3%) .002
30-day stroke and
death rate 18 (2%) 32 (0.9) .006
aTwo lethal strokes.
bFour lethal strokes.patching, and the presence of preoperative symptoms sig-
CoPaGeA, Cooperative Patient General Anesthesia.
CoPaGeA, Cooperative Patient General Anesthesia.
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variate analysis, the need for shunting, alternative arterial
closure techniques, and the presence of preoperative symp-
toms maintained their significance.
Follow-up results. Follow-up was available for 4157
interventions (96% of the study group) for a mean duration
of 40 months (range, 1-166 months). Less than 10% of the
patients had a phone interview as their unique follow-up.
During follow-up, 207 deaths, 45 ipsilateral and contralat-
eral neurological events, and 211 moderate-to-severe
(60%) restenoses were recorded.
Overall estimated 84-month survival, stroke-free sur-
vival, and restenosis-free survival rates were 88.5% (SE,
0.009), 87.9% (SE, 0.009), and 79.3% (SE, 0.01), re-
spectively.
There were no differences between the two groups in
terms of estimated 7-year survival (87.3% and 88.8%, re-
spectively; 95% CI, 0.57-1.08; OR, 0.8; Fig 1) and stroke-
free survival (86.8% and 88.1%, respectively; 95% CI, 0.59-
1.07; OR, 0.8; Fig 2). Also the 7-year rates of freedom from
any ipsilateral neurological event (98.9% and 98.3%, respec-
tively; P  .9, log rank  0.7) and from any ipsilateral and
contralateral neurological events (98.1% and 97.4%, respec-
tively; P  .9, log rank  0.2) were similar. Diabetic
patients had slightly poorer 7-year restenosis-free survival
rates than nondiabetics (77.4% and 82.2%, respectively;
95% CI, 0.6-1; OR, 0.8; P  .05; Fig 3).
Univariate analysis in diabetics failed to identify any
factor affecting the risk of any ipsilateral neurological events
ificant at univariate) analysis for 30-day stroke and death
Multivariate analysis
P 95% CI OR P
.7
.1
.4
.2
.2
1.1-3.8 2.1 .01
.006
.9
.08
1.3-7.8 3.2 .008
.002
2.8-9.4 5.1 .001
.001
1.2-3.1 2 .01
.006Table IV. Univariate and multivariate (for factors resulted sign
rate in the entire study group
Univariate analysis
Risk factor 30-day stroke and death rate
- Female gender 14/1311 (1%)
- Male gender 36/2994 (1.2%)
- Age 79 years 46/3662 (1.2%)
- Age 79 years 4/643 (0.6%)
- Coronary artery disease 13/933 (14%)
- No coronary artery disease 37/3372 (1.1%)
- Peripheral artery disease 21/1330 (1.5%)
- No peripheral artery disease 29/2975 (1%)
- Arterial hypertension 39/2963 (1.3%)
- No arterial hypertension 11/1342 (0.9%)
- Diabetes 18/883 (2%)
- No diabetes 32/3422 (0.9%)
- Contralateral occlusion 4/249 (1.6%)
- No contralateral occlusion 46/4056 (1.1%)
- Symptomatic 23/1470 (1.5%)
- Asymptomatic 27/2835 (1%)
- Local or CoPaGeA anesthesia 6/1418 (0.4%)
- General anesthesia 44/2887 (1.5%)
- Shunt insertion 18/493 (3.6%)
- No shunt insertion 32/3912 (1.9%)
- Patch closure 30/3293 (0.9%)
- No patch closure 20/1012 (1.9%)Table V. Univariate analysis for 30-day stroke and death
rate in group 1
883 CEAs in diabetic patients
30-day stroke and
death rate P
- Female gender 7/303 (2.3%)
- Male gender 11/580 (1.9%) .6
- Age 79 years 17/772 (2.2%)
- Age 79 years 1/111 (0.9%) .3
- Coronary artery disease 6/237 (2.5%)
- No coronary artery disease 12/646 (1.9%) .5
- Peripheral artery disease 9/369 (2.4%)
- No peripheral artery disease 9/514 (1.7%) .5
- Arterial hypertension 13/654 (2%)
- No arterial hypertension 5/229 (2.1%) .8
- Orally treated diabetes mellitus 16/782 (2%)
- Insulin-requiring diabetes mellitus 2/101 (2%) .9
- Contralateral occlusion 1/47 (2.1%)
- No contralateral occlusion 17/836 (2%) .9
- Symptomatic 5/287 (1.7%)
- Asymptomatic 13/596 (2.1%) .6
Preoperative symptoms
- Transient ischemic attack 3/163 (1.8%)
- Stroke 1/53 (1.8%)
- Vertebrobasilar 1/70 (1.4%) .8
- Local or CoPaGeA anesthesia 1/286 (0.3%)
- General anesthesia 17/597 (2.8%) .014
- Shunt insertion 3/123 (2.4%)
- No shunt insertion 15/760 (1.9%) .7
- Patch closure 13/701 (1.8%)
- No patch closure 5/182 (2.7%) .4during follow-up (Table VII).
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DM is a major risk factor for the development of
ischemic stroke. Patients with diabetes are more likely to
suffer from a stroke than nondiabetics,11 and their stroke is
associated with worse functional outcome and higher mor-
tality rates.12 For these reasons, diabetic patients might be
expected to derive particular benefit from CEA. However,
the increased prevalence of cardiovascular disease and of
cerebrovascular events among diabetics has been felt to
increase the risk for postoperative complications in diabet-
ics undergoing major vascular surgery.6 With respect to
CEA, the role of DM as a contributor to perioperative risk
is disputed. Some authors have demonstrated that patients
with DM who present for CEA are not at an increased
risk,7,8 while several others supported the role of DM as an
independent risk factor.4,13,14 Also, in our series, perioper-
ative results in diabetics were significantly poorer than
those obtained in nondiabetics, with a 2% rate of perioper-
ative stroke and death compared with 0.8% in nondiabetics.
As suggested by several authors,15 the increased risk in
diabetics seems to be mainly due to an increased rate of
perioperative mortality, since diabetes is correlated with
silent myocardial ischemia and an increased risk of all forms
of early and late cardiac mortality. Also in our series, dia-
betics had an increased risk of death but not of stroke with
respect to nondiabetics, even if the risk of any perioperative
neurological event was only numerically higher among
diabetics (1.9% and 1.2%, respectively). It can be theorized
that the higher prevalence of unstable features in carotid
plaques from diabetic patients than in those from nondia-
betics could explain the mild increase of perioperative neu-
rological complications in diabetics that were reported in
Table VI. Univariate and multivariate (for factors resulted
rate in group 2
Univariate analysis
Risk factor 30-day stroke and death
- Female gender 7/1008 (0.7%)
- Male gender 25/2414 (1%)
- Age 79 years 29/2890 (1%)
- Age 79 years 3/532 (0.5%)
- Coronary artery disease 7/696 (1%)
- No coronary artery disease 25/2726 (0.9%)
- Peripheral artery disease 12/962 (1.2%)
- No peripheral artery disease 20/2460 (0.8%)
- Arterial hypertension 26/2309 (1.1%)
- No arterial hypertension 6/1113 (0.5%)
- Contralateral occlusion 3/203 (1.4%)
- No contralateral occlusion 29/3219 (0.9%)
- Symptomatic 18/1184 (1.5%)
- Asymptomatic 14/2238 (0.6%)
- Local or CoPaGeA anesthesia 5/1132 (0.4%)
- General anaesthesia 27/2290 (1.1%)
- Shunt insertion 15/372 (3.9%)
- No shunt insertion 17/3050 (0.5%)
- Patch closure 17/2592 (0.6%)
- No patch closure 15/830 (1.8%)
CoPaGeA, Cooperative Patient General Anesthesia.other studies.16However, even in the presence of DM, our periopera-
tive risk remains largely below the limits recommended by
published guidelines, confirming the feasibility and safety
of CEA also in diabetic patients. We did not find any
differences between diabetics and nondiabetics in terms of
postoperative MI. This may be secondary to the extremely
low incidence of postoperative MI in general among our
CEA population, possibly attributed to our strategy of
extensive preoperative cardiac evaluation.17
In this study, we also examined specific predictors of
poor early and late outcome among diabetic patients in
more detail. We analyzed the role of different medical
management of DM in determining the results of CEA, and
we are aware of only two other published studies making
such a comparison. Axelrod et al6 reported, in a large series
of mixed vascular procedures from the Department of
Veteran Affairs (VA), that, after controlling for the main
cardiovascular comorbidities, neither insulin-treated nor
oral medication-treatedDMappeared to increase the risk of
postoperative death. Diabetes did appear to be a moderate
independent risk factor for nonfatal cardiovascular compli-
cations, but this increased risk was confined to patients with
diabetes with insulin treatment. Similarly, Stoner et al,14 in
a large series of more than 13,000 CEAs from the same VA
database, reported that the presence of insulin-treated DM
was found to be the strongest independent patient risk
factor for an adverse outcome on the basis of an increased
risk of cardiac events and death.
In our experience, we did not find any difference in
terms of perioperative results between patients with insulin-
requiring DM and patients with oral agent-controlled dia-
ificant at univariate) analysis for 30-day stroke and death
Multivariate analysis
P 95% CI OR P
.3
.3
.8
.5
.09
.9
1-4.2 2.1 .04
.01
0.8-1.9 1.2 .1
.03
4.4-18.6 9.1 .001
.001
1-4.5 2.4 .005
.003sign
ratebetes.
roup
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did not increase the risk of perioperative complications in
diabetics, confirming previous data from our group.18
We did not find any difference in terms of cumulative
30-day stroke and death rate between symptomatic and
asymptomatic diabetic patients, and this was also true when
a separate analysis for 30-day death and stroke rates was
performed. Of interest is the observation that, when com-
paring 30-day stroke and death rate in asymptomatic dia-
betic and nondiabetic patients, the corresponding values
were 2.1% and 0.7%, confirming that diabetes plays an
important role in increasing perioperative risk of CEA also
in asymptomatics, who are usually considered at lower
surgical risk, as suggested by the results in the entire study
group and in group 2. These results suggest the need for
careful selection of asymptomatic diabetic patients.
Other patients characteristics such as older age, the
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Fig. 1. Kaplan-Meier curve survival in gpresence of coronary artery disease and peripheral arterydisease, and technical issues, such as the need for shunting,
and the use of primary closure did not significantly affect
perioperative results in diabetics, while some of these fac-
tors (shunt use, primary closure) were found to be signifi-
cantly associated with worse perioperative results in the
whole study group and in group 2. One can suppose that
the extremely low incidence of overall complications in
group 1 is rendering it difficult to demonstrate a statistically
significant difference when one in fact exists (type II statis-
tical error).
The only factor significantly affecting perioperative
results in diabetics was the use of general anesthesia.
These results are similar to those reported by Rockman et
al.8 It is likely that there is significant bias in the choice of
the patients who undergo surgery with general anesthe-
sia, as partially confirmed by the results of univariate and
multivariate analysis in the entire cohort of patients: as
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strokes. This patient group would be at increased risk for
perioperative complications based on these innate fac-
tors. However, the observation that, in nondiabetics, the
use of general anesthesia increased perioperative risk at
univariate but not at multivariate analysis, could suggest
a stronger impact of the kind of anesthesia on diabetic
patients. Even if we found increased mortality but not
stroke rates with general versus local/regional anesthesia
in diabetics, one can suppose that these patients, having
an increased burden of cerebrovascular disease involving
both large and small intracranial vessels, could benefit
from the precise and sensitive neurologic monitoring
during CEA that occurs under regional anesthesia or
CoPaGeA technique.
We did not find any difference between diabetics and
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vious studies,21 suggesting the presence of diabetes can
both increase neointimal hyperplasia after arterial injury22
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of CEA.23
Despite the intrinsic limits of a nonrandomized, retro-
spective study with a large number of cases but with a
relatively small number of events, our analysis confirmed
that the presence of DM significantly increases the risk of
mortality, but not of neurological events, during CEA. In
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Table VII. Univariate analysis for the risk of any
ipsilateral neurological event during follow-up in group 1
Univariate analysis
Log-rank P 95% CI OR
Female gender 1.3 .2 0.5-8.8 2.2
Hyperlipemia 0.2 .7 0.3-5.5 1.3
Arterial hypertension 1.8 .2 0.6-10.1 2.5
Insulin-requiring diabetes mellitus 0.9 .4 0.1-1.7 0.4
Contralateral carotid occlusion 0.4 .6 0.6-7.8 2.1
Preoperative symptoms 1.7 .2 0.2-1.2 0.6
Clinical monitoring 0.2 .6 0.2-14.1 1.5
Kind of reconstruction 4.4 .09 0.01-1.3 0.2subgroup of diabetic patients.CONCLUSIONS
In our experience, carotid endarterectomy can be per-
formed with good results in diabetic patients, who are,
however, at higher risk for perioperative mortality than
nondiabetic patients. General anesthesia with instrumental
monitoring when compared with regional anesthesia or
CoPaGeA with neurologic monitoring is associated with
increased risk in diabetics by both univariate and multivar-
iate analyses. The need for insulin treatment does not seem
to affect early and late results of the intervention.
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